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whether a lymph node resection beyond a D1 lymphadenectomy is beneﬁcial. Experienced gastric
surgery centers, especially in Japan and Korea, have argued that a more extensive lymph node dis-
section that incorporates the next echelon of lymph nodes (D2 lymphadenectomy) improves staging
and outcome in gastric cancer patients.
Aim of the work: Was to assess the feasibility and safety of D2 gastrectomy in patients presented by
operable gastric cancer.
Patients and Methods: The study included thirty patients with operable gastric cancer who were
treated by D2 gastrectomy after preoperative assessment by laboratory and radiological
investigations. They were followed post operatively for complications and hospital stay and the his-
topathological criteria were assessed and analyzed.
Results: Twenty six patients had pyloric tumors and four having gastric body tumors were
included. Postoperative complications occurred in 20% of cases, these included wound infection,
bile leak, ascites and chest infection.s: Alexandria University,
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The incidence of gastric cancer is declining and inspite of this
fact; it remains the fourth most common cancer and the second
most common cause of cancer-deaths worldwide. 1 Over the
previous several decades, controversy over whether the added
morbidity and mortality of total gastrectomy over subtotal gas-
trectomy was accompanied by any improved survival per-
suaded most surgeons to use radical subtotal excisions for all
but proximal cancers. The only hope for the cure of stomach
cancer remains complete surgical extirpation of the cancer with
an adequate margin of normal tissue. 2 The addition of enbloc
removal of affected organs, such as the spleen, pancreas, colon,
and lateral segment of the left lobe of the liver (Segments II and
III), is considered appropriate for contiguous spread of the pri-
mary as long as no dissemination is apparent. Recent work
from Memorial Sloan-Kettering Cancer Center in New York
City demonstrates equivalent mortality for gastric resection
with and without en-bloc resection of adjacent organs. 3 How-
ever, the morbidity rates were higher in the group requiring
splenectomy and distal pancreatectomy. More postoperative
interventions were also necessary to treat complications in this
group. Other retrospective reviews and randomized controlled
trials have demonstrated increased morbidity and mortality
from splenopancreatectomy. 4 There is ongoing controversy
over whether a lymph node resection beyond a D1 lymphade-
nectomy is beneﬁcial. Experienced gastric surgery centers, espe-
cially in Japan and Korea, have argued that a more extensive
lymph node dissection that incorporates the next echelon of
lymph nodes (D2 lymphadenectomy) improves staging and
outcome in gastric cancer patients. (Figure 1) 5,6
Aim of the work: Was to assess the feasibility and safety of
D2 gastrectomy in patients presented by operable gastric
cancer.Figure 1 Sixteen stations of lymph nodes are arranged according
to the location and extension of the primary tumor (N0–N4) and
(D1–D4) means extent of lymphadenectomy: D1 (N1 level): the
perigastric nodes along the greater and lesser curvatures (stations
1–6). D2 (N2 level): nodes along the left gastric artery (station 7),
common hepatic artery (station 8), celiac trunk (station 9), splenic
hilus, and splenic artery (station 10 and 11). D3 (N3 level): lymph
nodes at stations 12–14, along the hepatoduodenal ligament and
the root of the mesentery. D4 (N4 level) up to 15 and 16 in the
paraaortic and the paracolic region. (According to Japanese
classiﬁcation). 6 R6: adopted from: Kim H.J., Karpeh M.S.,
Brennan M F. Standardization of the extent of lymphadenectomy
for gastric cancer: impact on survival. Advances in Surgery 2001,
35: 203–223 (0065–3411).2. Patients and methods
The study included thirty patients admitted to the Surgical
Oncology Unit of the Alexandria University Hospital pre-
sented with operable gastric cancer in the period between April
2010 and August 2012. They were diagnosed preoperatively by
esophago-gasrto-duodenoscopy and biopsy, CT scan of the
abdomen and pelvis. Patients with CT ﬁndings of liver metas-
tasis, peritoneal seedlings, malignant ascites or extensive
involvement of adjacent organs beyond respectability were ex-
cluded from the study. After informed consent all patients
were treated by D2 dissection i.e. D1 dissection in addition
to the removal of the omental bursa with the front leaf of
the transverse mesocolon, and the left gastric, common hepa-
tic, celiac and splenic artery nodes are cleared. The type of gas-
trectomy (distal or total) was done according to the site of the
tumor; distal gastrectomy was done if there is a free safety
margin of ﬁve cm beyond the proximal resection line otherwise
total gastrectomy was done.The steps of the operation were follows: an upper midline
incision extending below the umbilicus was done in all cases,
exploration was done to detect metastatic disease in the liver,
Douglas pouch or other organs that were not detected by pre-
operative CT examination.
The tumor itself was assessed to determine: (1) its position
in the stomach (antral, body or cardia); (2) The extent of the
tumor (circumferential and involvement of more than one sec-
tor of the stomach) and (3) The depth of invasion (involvement
of the serosa or otherwise, direct invasion of adjacent struc-
tures). The latter ﬁnding dictated the performance of an
adjoining organ resection (transverse colon, tail of the pan-
creas or a lobe of the liver) in addition to D2 lymphadenec-
tomy. Then the duodenum was widely ‘Kocherized’. The
omentum was separated from the colon and dissection was
continued onto the transverse mesocolon, taking the anterior
layer of the mesocolon with the omentum and taking care
not to damage the colonic vasculature. It was important to en-
sure that the correct plane was entered at the beginning of this
Figure 2 Separation of the anterior 2 leaﬂets of the transverse
mesocolon together with the greater omentum from the posterior 2
leaﬂets of the transverse mesocolon.
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the omentum at the mid-colonic level and be guided by the
middle colic vessels. This dissection was carried to the right
with identiﬁcation of the right gastroepiploic vessels, the sur-
rounding lymphatics (including the sub-pyloric lymph nodes)
were swept up with the vessels; these were ligated with 2/0 vi-
cryl at their origin. The dissection was carried onto the pan-
creas taking the pancreatic capsule with the specimen.
(Figure 2)
If it is proving difﬁcult to separate the pancreatic capsule at
this point, attention is directed to the lesser omentum. The
omentum is placed back in the abdomen and an assistant re-
tracts the liver in a cephalic direction; it may be helpful to have
a reverse trendelenberg tilt on the table at this time. The reﬂec-
tion of the lesser omentum on the liver is divided, starting at
the hiatus and working to the right side. In dissecting from
above downward the right gastric artery is ligated at its origin
and divided.
If a total gastrectomy is being performed for a more prox-
imal tumor then after division of the lesser omentum it is often
helpful to dissect the hiatus mobilizing the lower esophagus.
After ligation of the right gastric artery, the duodenum is
mobilized from the pancreas. At this stage, a number of small
vessels are often encountered and should be ligated and not
diathermised. The duodenum (>2 cm from the pylorus) can
now be divided between two crushing clamps. The duodenal
stump is closed with a continuous 3/0 vicryl suture which is
then inverted with a second 3/0 prolene layer of closure.Figure 3 Splenic artery completely scletonized.Alternatively, a linear cutting/stapling device can be used to di-
vide the duodenum; however, it is our practice to bury the sta-
ple line with a continuous 3/0 prolene suture. Separation of the
pancreatic capsule and dissection along the common hepatic
artery is now carried out. The transected duodenum and stom-
ach are lifted out of the wound and to the left, the common he-
patic artery identiﬁed and cleared, removing the tissue inferior
to this with the pancreatic capsule. The left gastric vein is iden-
tiﬁed and ligated. The left branch of the gastroepiploic arcade
is divided and the lowest short gastric vessels ligated and di-
vided. The stomach and omentum can then be lifted forwards
exposing the celiac axis and left gastric artery from below. The
tissue from around the celiac axis and splenic artery are swept
forward and included with the left gastric artery which is dou-
ble ligated with 2/0 vicryl and divided. (Figure 3)
At the end of this dissection the pancreas is skeletonised as
are the hepatic and splenic arteries. The stomach, at this point,
is prepared for the transection by ensuring that it is cleaned to
its wall, this will involve dividing tissue adherent to the high
lesser curve which will include the right cardiac nodes. On
the greater curve side of the stomach the remaining short gas-
tric vessels supply the gastric remnant. If a total gastrectomy is
planned the remaining short gastric vessels are ligated as close
to the spleen as possible and the remainder of the pancreatic
capsule stripped from the pancreatic tail. After distal gastrec-
tomy, gastrojejunostomy was done and after total gastrec-
tomy, roux en-Y esophagojejunostomy was done.
As regards postoperative management: the initial postoper-
ative care focused on the administration of adequate analgesia,
maintenance of ﬂuid and electrolyte balance and chest physio-
therapy. The patients were routinely nursed in a high depen-
dency unit and monitored with hourly blood pressure, pulse,
urinary volumes and central venous pressure recordings for
the ﬁrst 24 h. Humidiﬁed oxygen was administered at an appro-
priate concentration to ensure an oxygen saturation of
>95 mm Hg. The gastric lumen was decompressed by nasogas-
tric tube which is left on free drainage until bowel motion was
regained; thereafter, feeding was introduced. Drains were re-
moved on the 6th postoperative day routinely and the patient
was discharged on the seventh postoperative day unless postop-
erative complications occurred. Sutures were removed 15 days
after surgery. Postoperative complications were searched for
and recorded.
The results are tabulated and analyzed by The Statistical
Package for the Social Sciences (SPSS) software version 15
for windows. Qualitative data was analyzed using Fisher Exact
and Monte Carlo tests. Also comparison between quantitative
data was analyzed using student t-test and F-test (ANOVA).3. Results
The majority of the studied patients were males (26 males and 4
females). The male to female ratio was 6.5: 1. The ages ranged
from 29 to 70 years and the mean age was 50.93 ± 9.77 years.
Gastric outlet obstruction was the presentation in 10 patients
(33.3%). One case presented acutely with gastric perforation
that was initially explored and diagnosed by biopsy. The subse-
quent deﬁnitive procedure of D2 gastrectomy was performed
3 weeks later. The tumor was located in the pyloric antrum in
26 patients (87%) while 4 cases of gastric body tumors were
included in the study.
Table 1 Relation of N stage with age site and T stage of the tumor and the relation between postoperative complications with Type of
gastrectomy.
N stage F (p)
N0 (n= 19) N1 (n= 10) N2 (n= 1)
Age (years)
Range 29–70 42–66 38
Mean ± SD 50.74 ± 10.55 52.60 ± 7.95 38.00 ± – 1.028 (0.371)
Tumor site (cms)
Range 3–8 4–8 8 2.995 (0.067)
Mean ± SD 5.26 ± 1.22 5.90 ± 1.20 8.00 ± –
N stage
N0 N1 N2 No Test of sig.
No. % No. % No. %
Tumor site
Pylorus 18 69.2 7 26.9 1 3.9 26 MCp = 0.649
Body 1 25 3 75 0 0.0 4
T stage
T2a 1 100.0 0 0.0 0 0.0 1 MCp = 0.714
T2b 10 68.8 5 31.3 0 0.0 15
T3 7 53.8 5 38.5 1 7.7 13
T4 1 100.0 0 0 0 0 1
Postoperative complications No Test of sig.
No Bile leak Ascites Minor wound
infection
No. % No. % No. % No. %
Type of gastrectomy
Distal 20 76.92 2 7.7 1 3.85 3 11.53 26 MCp = 1.000
Total 4 100.0 0 0.0 0 0.0 0 0.0 4
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ings were as follows: in 16 patients the tumor did not reach
the serosa, while the serosa was apparently involved without
invading nearby organs in 13 patients. Invasion of the trans-
verse colon was encountered in one patient. Omental bursec-
tomy was easily performed in all cases. The celiac trunk and
its branches were identiﬁed and dissected with ligation of the
left gastric vessels and skletonisation of the splenic and he-
patic arteries. And multiple palpable lymph nodes were iden-
tiﬁed along the course of the left gastric artery in 10 cases.
The areolar tissue around the common hepatic artery was
free of any palpable lymph nodes in all cases. There were
no enlarged nodes along the course of the splenic artery
or around the celiac trunk. The splenic hilar lymph nodes
were not enlarged in any of the cases who had pyloric tu-
mors although they were enlarged in 2 cases with gastric
body tumors. The right paracardial tissue was removed in
all cases while both the left and right paracardial tissue
was removed in cases with gastric body tumors. In all pa-
tients there were no palpable lymph nodes. For pyloric tu-
mors, distal gastrectomy with 5 cm safety margin
proximally and to the ﬁrst part of the duodenum distally
was done with D2 lymphadenectomy and reconstruction
by antecolic gastrojejunostomy. Total gastrectomy with D2
lymphadenectomy was done for tumors involving the gastric
body with reconstruction by roux en y esophagojejunosto-
my. The spleen was removed in all cases that had totalgastrectomy because of enlargement of splenic hilar nodes
(2 cases) or proximity of the tumor to the spleen (2 cases)
and was preserved in all cases that had distal gastrectomy.
In one case transverse colectomy was done in which case
the tumor was found to invade the serosa of the transverse
colon and the transverse mesocolon. The mean operative
time was 2.64 ± 0.39 (ranging from 2.5 to 3.5) hours. No
intraoperative complications were encountered.
The postoperative period was smooth and unremarkable in
24 cases (80%). Postoperative complications occurred in 6 pa-
tients (20%) in the form of minor wound infection and gaping
(3 cases: 10%) which stopped spontaneously after 5–7 days of
conservative treatment. Bile leakage (2 cases: 6.67%) cases de-
tected by bile stained ﬂuid in the drain which was of small
amount and closed spontaneously after 3 and 5 days of conser-
vative treatment. Both cases had a history of cholecystectomy.
Postoperative ascites was detected in one case (3.33%) which
was ascribed to postoperative hypoalbuminaemia and retro-
peritoneal raw area. This was treated medically and relieved
after one month. Chest infection occurred in 3 patients that re-
quired medical treatment and respiratory exercises. There were
no postoperative complications related to associated organ
resection. In addition, the hospital mortality rate was nil.
The mean tumor size was 5.57 ± 1.29 (range from 3–8)
cms. According to TNM staging system, 1 case had T2a tumor
(3.3%), 15 cases had T2b tumor (50%), 13 cases had T3 tumor
(43.3%) and 1 case had T4 tumor (3.3%). As regards tumor
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noma, 22 cases (73.33%) had moderately differentiated adeno-
carcinoma and 5 cases (16.67%) had poorly differentiated
adenocarcinoma
The mean number of lymph nodes dissected and examined
pathologically was 19.00 ± 2.68 (range from 15–25) LNs.
Metastatic deposits in lymph nodes were detected in 11 cases;
eight of them had pyloric tumor and three cases had gastric
body tumor. The number of involved lymph nodes ranged
from 3 to 9 lymph nodes. According to TNM staging system,
19 patients had N0 stage, 10 patients had N1 stage and one pa-
tient had N2 stage. The N stage was studied in relation to tu-
mor size and age of the patient and although was statistically
insigniﬁcant (P value: 0.067 and 0.371, respectively), the rela-
tion was borderline with tumor size. Studying the N stage of
the tumor in relation to tumor site and T stage was statistically
insigniﬁcant (P values were 0.649 and 0.714, respectively). N
stage was signiﬁcantly correlated with histological grade of
the tumor (p value: 0.009). Studying the occurrence of postop-
erative complications in relation to the type of gastrectomy
(distal or total) and was insigniﬁcant (P value: 1.000). On
the other hand, the postoperative hospital stay was signiﬁ-
cantly prolonged when postoperative complications occurred
(P value: <0.001). Table 1.4. Discussion
Patients with larger tumors had more invasion into the gastric
wall in terms of depth of invasion and more frequent lymph
node metastasis than did patients with smaller tumors. Tumor
size clinically serves as a simple predictor of tumor progression
and survival of patients in gastric carcinoma. 7 The incidence of
lymph node metastases increases with invasive tumors larger
than 30 mm as there was increased incidence of lymphatic-
vascular involvement with an increased risk of LN metastases.
8 Previous studies indicated the signiﬁcance of tumor diameter
by dividing patients into three groups: <40 mm, P40 to
<100 mm, and P100 mm. Another study deﬁned a large
gastric tumor as one P100 mm in diameter. However, other
reports have deﬁned the optimal cutoff value of tumor diameter
as 80 mm. These conﬂicting results might be due to differences
in the number of patients, lymph node dissections, or treat-
ments after surgery. In the same study, larger tumors were
associated with increased incidence of lymph node metastases
and poor prognosis. 9
From the present study and Takeo et al. 10 study, it was
noted that lymph node metastases were located mainly in the
perigastric nodes (N1 nodes) then to N2 nodes mainly the left
gastric artery nodes (group 7), common hepatic nodes (group
8) and splenic hilar nodes (group 10). The incidence of
metastases to any perigastric node station was highest when
the tumor was located close to it, even though there was little
variation in the metastatic pattern along the lesser curvature
between tumors in the different thirds (upper, middle or lower
thirds). Station numbers 2 (left paracardial) and 5 (supra-
pyloric) had the lowest incidence of metastatic deposits for
all locations of tumors. The position of the tumor on different
parts of the stomach circumference had a similar impact.
Proximal third tumors along the lesser curvature or on the
anterior or posterior walls had splenic hilar node metastases
in up to 6%, compared to 32% for tumors at the greatercurvature. 11 Total gastrectomy has a higher morbidity and
hospital stay than distal gastrectomy and there is no survival
beneﬁt from a total gastrectomy if resection margins are free
of tumor. The resection of the spleen or the pancreas in asso-
ciation with total gastrectomy is an important risk factor for
morbidity and hospital mortality after D2 dissection. 12
In the Turkish study 13, postoperative complications in
patients treated by D2 gastrectomy occurred in 35% of cases
(there was lymphatic leakage resulted from retroperitoneal
dissection in 29 patients, wound infection in one patient,
anastomotic leakage in one, ileus in two, and nonsurgical
complications in six patients). In the same study, surgical
complications in the D1 group were found in 8.8% (wound
infection in three patients, duodenal stump dehiscence in
one, anastomotic leakage in one, ileus in one, and four patients
had nonsurgical complications i.e. pulmonary and cardiac).
10.46% of patients who were treated by D2 gastrectomy in
Kunisaki et al. 14 study had postoperative complications
(pulmonary disorders, renal dysfunction, anastomotic leakage,
hemorrhage, injury of the biliary tract, pancreatic ﬁstula,
wound infection, ileus and heart failure) while 39.3% of
patients who were treated by D3 gastrectomy had postopera-
tive complications (pulmonary disorders, renal dysfunction,
anastomotic leakage, hemorrhage, injury of the biliary tract,
pancreatic ﬁstula, wound infection, ileus and heart failure).
5. Conclusion
D2 gastrectomy is a safe procedure in patients with operable
gastric cancer in well trained hands. The higher the size of
the tumor the higher incidence of lymph node metastasis also
this was not signiﬁcant. Splenic hilar nodes were the most
commonly involved among the N2 nodes in gastric body
tumors.
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